Dani Blum is a Health Reporter at The Times. She has extensively covered Covid-19 since the pandemic's onset and has reported on the implications of Ozempic since 2022, with a focus on medicine, healthcare, and wellness. Dani's work has been featured in numerous outlets, including The New York Times, The Sydney Morning Herald, and Yahoo News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Dani Blum’s coverage focuses heavily on healthcare, pharmaceuticals, and lifestyle topics. She frequently cites data in her articles, indicating a preference for evidence-based insights. Pitches should aim to offer credible research or expert opinions supported by data.
Given the focus on weight loss medications and health-related topics, experts from the medical field with experience in pharmacology, nutrition, or related specialties may find success when pitching to Dani. Additionally, pitches that tie into current trends in healthcare technology such as telehealth could also be of interest.
While Dani's geographic focus is national (United States), she covers a broad range of health-related topics which are not specific to any particular region within the US.
This information evolves through artificial intelligence and human feedback. Improve this profile .
California has declared a state of emergency over bird flu. How worried should you be? Here's what experts say
Zepbound is the first prescription drug approved specifically to treat the sleep disorder. Millions of Americans have sleep apnea, and many also have obesity.
By: Dani Blum
The letter came in June. Mindy McCormick, 67, read that her insurer would soon stop covering the weight loss drug Wegovy, which she had been taking for more than two years.
Dani Blum New York Times The letter came in June. Mindy McCormick , 67, read that her insurer would soon stop covering the weight loss drug Wegovy, which she had been taking for more than two years.
By Dani Blum | The New York Times Have a flexible spending account? Amazon has a page for you.
By: Dani Blum
Experts expect cases to rise again this winter. Here’s the latest on symptoms, treatments and testing.
Dani Blum The New York Times Company Americans are drinking more as they hit midlife — and suffering the consequences.
What does the science say about its health effects? What foods will be affected? And other common questions about the newly banned additive.
The flu is raging across the United States. The antiviral Tamiflu can ease symptoms and speed recovery, but there's a catch.
Could a diabetes and weight loss drug benefit the brain? Here’s what scientists are learning.
(833) 317-6278 
